CONCORMED
ActiveSummary
CONCORMED has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,558 and a net result of €50,633. Equity is shrinking by about 4.3% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
07-04
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
03-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
06-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Weakest financial yearnet €14,477 ▼77.5%
Net result drops to €14,477, the lowest in the series; recovery starts the following year.
01-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Highest result from 2020 to 2025net €64,376 ▲73%
Operating result €81,833, net result €64,376, both a record.
31-12
Financial
Equity above €100,000equity €104,583 ▲160%
A profit in every financial year since 2020 builds equity to €104,583.
09-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 9 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.